AlphaCentric Advisors LLC Makes New Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

AlphaCentric Advisors LLC bought a new stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 17,684 shares of the company's stock, valued at approximately $374,000.

A number of other large investors have also bought and sold shares of SGRY. KBC Group NV raised its position in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company's stock worth $77,000 after purchasing an additional 576 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. increased its holdings in Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock valued at $124,000 after purchasing an additional 3,379 shares during the last quarter. Creative Planning bought a new position in Surgery Partners during the third quarter worth about $258,000. Versor Investments LP acquired a new position in shares of Surgery Partners during the 3rd quarter worth about $271,000. Finally, MeadowBrook Investment Advisors LLC increased its stake in shares of Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after acquiring an additional 1,460 shares during the last quarter.

Surgery Partners Stock Performance

Shares of Surgery Partners stock traded down $0.15 during trading on Thursday, hitting $25.67. 752,774 shares of the stock were exchanged, compared to its average volume of 1,441,475. The company has a fifty day moving average price of $22.52 and a 200-day moving average price of $26.68. The stock has a market capitalization of $3.26 billion, a price-to-earnings ratio of -53.48, a price-to-earnings-growth ratio of 19.34 and a beta of 2.60. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 1-year low of $19.50 and a 1-year high of $34.10.

Insider Activity at Surgery Partners

In other news, CEO Jason Eric Evans sold 26,520 shares of Surgery Partners stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.65, for a total transaction of $680,238.00. Following the completion of the sale, the chief executive officer now owns 560,698 shares of the company's stock, valued at approximately $14,381,903.70. This trade represents a 4.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Harrison R. Bane sold 56,315 shares of Surgery Partners stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the completion of the sale, the insider now owns 107,037 shares of the company's stock, valued at $2,744,428.68. This trade represents a 34.47 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 96,733 shares of company stock worth $2,480,106. Company insiders own 2.30% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have commented on SGRY shares. Royal Bank of Canada lowered their target price on shares of Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a research note on Wednesday, November 20th. Macquarie restated an "outperform" rating and set a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. Bank of America initiated coverage on Surgery Partners in a research note on Monday, December 16th. They issued a "buy" rating and a $30.00 target price on the stock. Finally, JPMorgan Chase & Co. lowered their price target on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research note on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $36.56.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.